RIPK3 and ovarian carcinoma: TNFα appeared to be required for death, as a TNFα-neutralizing antibody was able to rescue cell survival in ovarian carcinomas expressing endogenous (Figure 5d) or ectopic (Figure 5e) RIPK3.